Completed PHASE2 INTERVENTIONAL 2-arm NCT00710242

Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Assess the Safety and Efficacy or Pre-Treatment With DF01 During Late Pregnancy in Reducing Prolonged Labor

Sponsor: Dilafor AB

Conditions Labor Pregnancy

Interventions DF01 Placebo

Updated 6 times since 2017 Last updated: May 18, 2009 Started: Apr 30, 2007 Primary completion: Mar 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Labor and Pregnancy, this trial is completed. The trial is conducted by Dilafor AB and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dilafor AB

Data source: Dilafor AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Borås, Sweden , Gothenburg, Sweden , Gävle, Sweden , Huddinge, Sweden , Jönköping, Sweden , Kalmar, Sweden , Linköping, Sweden , Lund, Sweden , Norrköping, Sweden , Nyköping, Sweden and 7 more locations